secwatch / observer
8-K/A filed October 31, 2023, 7:59 PM ET ticker BMY CIK 0000014272
leadership confidence high sentiment neutral materiality 0.60

Bristol-Myers details CEO succession; Caforio to retire April 1, 2024, Boerner Chairman

BRISTOL MYERS SQUIBB CO

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Giovanni Caforio

Director
BMY · BRISTOL MYERS SQUIBB CO
Effective
2024-04-01
Filed
October 31, 2023, 7:59 PM ET
On October 25, 2023, Dr. Caforio advised the Board that he will not stand for re-election to the Board at the 2024 Annual Meeting of Shareholders, and will retire from the Board, effective April 1, 2024.
Appointed

Christopher Boerner

Chief Executive Officer
BMY · BRISTOL MYERS SQUIBB CO
Effective
2023-11-01
Filed
October 31, 2023, 7:59 PM ET
appointment of Christopher Boerner, Ph.D. as Chief Executive Officer by the Board, effective November 1, 2023
Appointed

Christopher Boerner

Chairman of the Board
BMY · BRISTOL MYERS SQUIBB CO
Effective
2024-04-01
Filed
October 31, 2023, 7:59 PM ET
the Board approved the appointment of Dr. Boerner as Chairman of the Board in addition to Chief Executive Officer, effective April 1, 2024
Role change

Giovanni Caforio

Executive Chairman
BMY · BRISTOL MYERS SQUIBB CO
Effective
2023-11-01
Successor
Christopher Boerner
Filed
October 31, 2023, 7:59 PM ET
retirement of Giovanni Caforio, M.D. as Chief Executive Officer and his election as Executive Chairman of the Board of Directors of the Company (the “Board”), effective November 1, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Giovanni Caforio departed as Director at BRISTOL MYERS SQUIBB CO.

Action
retire
Role
Director
Exact text from the filing
On October 25, 2023, Dr. Caforio advised the Board that he will not stand for re-election to the Board at the 2024 Annual Meeting of Shareholders, and will retire from the Board, effective April 1, 2024.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher Boerner was appointed as Chief Executive Officer at BRISTOL MYERS SQUIBB CO.

Action
appointed
Role
Chief Executive Officer
Exact text from the filing
appointment of Christopher Boerner, Ph.D. as Chief Executive Officer by the Board, effective November 1, 2023
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher Boerner was appointed as Chairman of the Board at BRISTOL MYERS SQUIBB CO.

Action
appointed
Role
Chairman of the Board
Exact text from the filing
the Board approved the appointment of Dr. Boerner as Chairman of the Board in addition to Chief Executive Officer, effective April 1, 2024
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Giovanni Caforio was appointed as Executive Chairman at BRISTOL MYERS SQUIBB CO.

Action
appointed
Role
Executive Chairman
Exact text from the filing
retirement of Giovanni Caforio, M.D. as Chief Executive Officer and his election as Executive Chairman of the Board of Directors of the Company (the “Board”), effective November 1, 2023
View on SEC.gov

BRISTOL MYERS SQUIBB CO filing history →

Source: SEC EDGAR
accession 0001140361-23-050518
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.